AEON Biopharma Inc. [AMEX: AEON] price surged by 62.86 percent to reach at $0.88.
The one-year AEON stock forecast points to a potential upside of 62.0. The average equity rating for AEON stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on AEON Biopharma Inc. [AEON]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AEON shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AEON stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for AEON Biopharma Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 18, 2023.
AEON Stock Performance Analysis:
AEON Biopharma Inc. [AEON] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 123.53. With this latest performance, AEON shares gained by 50.99% in over the last four-week period, additionally sinking by -67.66% over the last 6 months – not to mention a drop of -69.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AEON stock in for the last two-week period is set at 70.40, with the RSI for the last a single of trading hit 84.51, and the three-weeks RSI is set at 57.07 for AEON Biopharma Inc. [AEON]. The present Moving Average for the last 50 days of trading for this stock 1.4700, while it was recorded at 1.3800 for the last single week of trading, and 6.0200 for the last 200 days.
Insight into AEON Biopharma Inc. Fundamentals:
AEON Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.16 and a Current Ratio set at 0.16.
AEON Biopharma Inc. [AEON] Institutonal Ownership Details
The top three institutional holders of AEON stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in AEON stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in AEON stock with ownership which is approximately 5.1238%.
